This article explores the many challenges to creating a pharmaceutical development program for the treatment of a rare disease.
By Applied Clinical Trials Editors
The EU-AIMS Longitudinal European Autism Project (LEAP) is combining genetic testing, neuroimaging, cognitive testing and clinical assessments to identify biological risk markers associated with subtypes of autism.
Alzheimer’s disease is and will remain one of the most unyielding public health crises of the 21st century.
An investigation published by the BMJ this week has raised new concerns about the validity of a trial that was used to gain approval for Xarelto from the U.S. and European regulators.
Amgen, Celgene, Independence Blue Cross, Bank of America and many more collaborate to deliver immunotherapies more quickly to cancer patients through historic drug development alliance.
New Phase I clinical in Miami offers gateway location to Latin America.
The Rater Station℠ platform has been used extensively in Central Nervous System clinical trials, and version 4.0 is currently being used in two clinical trials that are actively recruiting.
The sponsors will use CRF Health's TrialMax® platform to support data capture for quality of life issues during the post-progression phase.